Details of the Drug

General Information of Drug (ID: DMCJ2NW)

Drug Name

INXN 2001

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01397708) Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma. U.S. National Institutes of Health.